The New American Urological Association Benign Prostatic Hyperplasia Clinical Guidelines: 2019 Update
The New American Urological Association Benign Prostatic Hyperplasia Clinical Guidelines: 2019 Update
复制标题
DOI：
10.1007/s11934-020-00985-0
复制
发表时间：
2020-07-01
影响因子：
2.6
通讯作者：
McVary, Kevin T.
中科院分区：
文献类型：
--
作者：
Dornbier, Ryan;Pahouja, Gaurav;McVary, Kevin T.
综述目的：本文旨在分析目前手术治疗良性前列腺增生（BPH）相关下尿路症状（LUTS）的有效性。最近的发现有显着的手术进步治疗BPH，包括微创手术技术（MISTs）的日益发展和利用。这些程序有不同的结果，理解这些结果至关重要。此外，微创手术有重要的不良反应，但与更具侵入性的手术技术相比，对性功能的影响最小。重要的是所有泌尿科医生要熟悉的手术技术，可用于治疗前列腺增生症和更新的美国泌尿外科协会（AUA）指南。评估疗效、安全性和性功能的进一步研究将有助于指导未来的护理和发展实践。
Purpose of Review The goal of this paper was to analyze the efficacy of the current modalities available to surgically treat lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Recent Findings There have been significant surgical advancements for the treatment of BPH, including an increasing development and utilization of minimally invasive surgical techniques (MISTs). These procedures have varying outcomes that are critical to understand. In addition, MISTs have important adverse effects, though have minimized effects on sexual function when compared to more invasive surgical techniques. It is important for all urologists to be familiar with the surgical techniques available to treat BPH and the updated American Urological Association (AUA) Guidelines. Further studies evaluating efficacy, safety, and sexual functioning will help guide care in the future and evolve practice.